156 related articles for article (PubMed ID: 37580183)
21. Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults.
Bassetti M; Righi E; Del Giacomo P; Sartor A; Ansaldi F; Trucchi C; Alicino C; Trecarichi EM; Spanu T; Paganino C; Tumbarello M; Carnelutti A
J Am Geriatr Soc; 2018 Jul; 66(7):1284-1289. PubMed ID: 29664994
[TBL] [Abstract][Full Text] [Related]
22.
Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
[TBL] [Abstract][Full Text] [Related]
23. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.
Minejima E; Bensman J; She RC; Mack WJ; Tuan Tran M; Ny P; Lou M; Yamaki J; Nieberg P; Ho J; Wong-Beringer A
Crit Care Med; 2016 Apr; 44(4):671-9. PubMed ID: 26540400
[TBL] [Abstract][Full Text] [Related]
24. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist.
Hadano Y; Kakuma T; Matsumoto T; Ishibashi K; Isoda M; Yasunaga H
Int J Infect Dis; 2021 Feb; 103():308-315. PubMed ID: 33278619
[TBL] [Abstract][Full Text] [Related]
25. Mortality in Staphylococcus aureus bacteraemia remains high despite adherence to quality indicators: secondary analysis of a prospective cohort study.
Willekens R; Puig-Asensio M; Suanzes P; Fernández-Hidalgo N; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Pigrau C; Almirante B
J Infect; 2021 Dec; 83(6):656-663. PubMed ID: 34626700
[TBL] [Abstract][Full Text] [Related]
26. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
27. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
28. Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.
Chong YP; Park SJ; Kim HS; Kim ES; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Medicine (Baltimore); 2013 Mar; 92(2):98-108. PubMed ID: 23429353
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil.
Riche CVW; Cassol R; Falci DR; Ramirez M; Dias CAG
PLoS One; 2023; 18(4):e0283774. PubMed ID: 37053222
[TBL] [Abstract][Full Text] [Related]
30. agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Kang CK; Kim YK; Jung SI; Park WB; Song KH; Park KH; Choe PG; Jang HC; Lee S; Kim YS; Kwak YG; Kwon KT; Kiem S; Kim CJ; Kim ES; Kim HB;
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2187-2191. PubMed ID: 28639163
[TBL] [Abstract][Full Text] [Related]
31. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
Nagao M; Yamamoto M; Matsumura Y; Yokota I; Takakura S; Teramukai S; Ichiyama S
Infection; 2017 Feb; 45(1):83-91. PubMed ID: 27709434
[TBL] [Abstract][Full Text] [Related]
32. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
Britt NS; Patel N; Shireman TI; El Atrouni WI; Horvat RT; Steed ME
J Antimicrob Chemother; 2017 Feb; 72(2):535-542. PubMed ID: 27999028
[TBL] [Abstract][Full Text] [Related]
33. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
[TBL] [Abstract][Full Text] [Related]
34. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
[TBL] [Abstract][Full Text] [Related]
35. Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
Rosa R; Wawrzyniak A; Sfeir M; Smith L; Abbo LM
J Hosp Med; 2016 Jan; 11(1):27-32. PubMed ID: 26381394
[TBL] [Abstract][Full Text] [Related]
36. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
[TBL] [Abstract][Full Text] [Related]
37. Integration of FDG-PET/CT in the Diagnostic Workup for Staphylococcus aureus Bacteremia: A Prospective Interventional Matched-cohort Study.
Ghanem-Zoubi N; Kagna O; Abu-Elhija J; Mustafa-Hellou M; Qasum M; Keidar Z; Paul M
Clin Infect Dis; 2021 Dec; 73(11):e3859-e3866. PubMed ID: 32639560
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Gao W; Christiansen KJ; Coombs GW; Johnson PD; Howden BP
J Infect Dis; 2011 Aug; 204(3):340-7. PubMed ID: 21742831
[TBL] [Abstract][Full Text] [Related]
39. Interleukin (IL)-1β and IL-10 Host Responses in Patients With Staphylococcus aureus Bacteremia Determined by Antimicrobial Therapy.
Volk CF; Burgdorf S; Edwardson G; Nizet V; Sakoulas G; Rose WE
Clin Infect Dis; 2020 Jun; 70(12):2634-2640. PubMed ID: 31365924
[TBL] [Abstract][Full Text] [Related]
40. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
Gudiol C; Cuervo G; Shaw E; Pujol M; Carratalà J
Expert Opin Pharmacother; 2017 Dec; 18(18):1947-1963. PubMed ID: 29115883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
